WAYNE, N.J.--(EON: Enhanced Online News)--MAQUET Medical Systems USA, a leading supplier of medical equipment for operating, hybrid and induction rooms, intensive care units and patient transport, today announced the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the VOLISTA Surgical Lighting System. VOLISTA, an extension of the TRIOP™ light assembly, is the first lighting system that allows surgeons the flexibility to easily configure the equipment to meet the needs of the procedure, instead of working within the confines of a static operating room.
“The VOLISTA system is another addition to our portfolio of hospital lighting that enables surgeons to configure the operating room in the way they find most useful and productive, based on the procedure that they are conducting”
“The VOLISTA system is another addition to our portfolio of hospital lighting that enables surgeons to configure the operating room in the way they find most useful and productive, based on the procedure that they are conducting,” said Raoul Quintero, President of MAQUET Medical Systems USA. “Furthermore, the VOLISTA system allows operating rooms to become more versatile and used for a wide variety of procedures, ultimately helping to ensure that each operating room in the hospital is being maximized.”
VOLISTA surgical lighting system incorporates MAQUET’s innovative Luminance Management Device (LMD) technology, providing surgeons a clear and accurate view of anatomical structures during surgery, minimal peripheral reflections and assurance of equivalent light levels. The VOLISTA system also offers the choice of three color temperatures (3900, 4500 or 5100°K) to adapt the illumination based on the surgery being performed.
MAQUET, a trusted partner for hospitals and physicians for over 175 years, is the global leader in providing medical systems that meet the needs of the most medically challenging patients, while exceeding the expectations of the hospital teams that care for them. MAQUET designs, develops and distributes innovative therapy solutions and infrastructure capabilities for high-acuity areas within the hospital including the operating room (OR), hybrid OR/cath lab and intensive care unit (ICU) as well as intra and inter hospital patient transport.
Headquartered in Rastatt, Germany, MAQUET is the largest subsidiary of the publicly listed Getinge Group AB of Sweden. MAQUET generated about 1.5 billion Euros in 2012, representing more than half of the Getinge Group’s annual revenue of 2.7 billion Euros. MAQUET has 6,300 employees in 45 international sales and service organizations, as well as a network of more than 300 sales representatives. For more information please visit www.maquet.com.